Fecal calprotectin and fecal indole predict outcome of fecal microbiota transplantation in subjects with recurrent Clostridium difficile infection

被引：12
|
作者：
Hibbard, J. [1 ]
Jiang, Z. -D. [2 ,3 ]
DuPont, H. L. [2 ,3 ,4 ,5 ]
机构：
[1] Ohio Wesleyan Univ, Delaware, OH 43015 USA
[2] Kelsey Res Fdn, Houston, TX USA
[3] Univ Texas Sch Publ Hlth, Houston, TX USA
[4] Univ Texas McGovern Med Sch, 1200 Pressler St,Suite 743, Houston, TX 77030 USA
[5] Baylor Coll Med, Houston, TX 77030 USA
来源：
ANAEROBE | 2019年 / 56卷
关键词：
Calprotectin; Indole; IBD; FMT; C. difficile infection;
D O I：
10.1016/j.anaerobe.2019.03.006
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Fecal calprotectin and indole were studied in 134 subjects with recurrent CDI before and after FMT. Reduced fecal calprotectin (p = 0.0353, 95% CI 0.1305-0.1439) and rising levels of indole (p < 0.0001, 95% CI < 0.0001-0.0003) predicted successful treatment. A ratio of recal calprotectin/indole may provide prognostic value for FMT (p = 0.0004, 95% CI 0.22-0.87). (C) 2019 The Authors. Published by Elsevier Ltd.
引用
收藏
页码：102 / 105
页数：4
相关论文
共 50 条
  • [41] Fecal microbiota transplantation in treating Clostridium difficile infection in Taiwan
    Chu, Chia-Sheng
    Chuang, Shih-Chieh
    Chen, Hung-Yao
    Hsu, Wei-Fan
    Tseng, Cheng-En
    Chiang, Cheng-Yuan
    Chang, Chia-Hsi
    Cheng, Ken-Sheng
    Chou, Jen-Wei
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 503 - 503
  • [42] SUCCESSFUL THERAPY OF CLOSTRIDIUM DIFFICILE INFECTION WITH FECAL MICROBIOTA TRANSPLANTATION
    Konturek, P. C.
    Koziel, J.
    Dieterich, W.
    Haziri, D.
    Wirtz, S.
    Glowczyk, I.
    Konturek, K.
    Neurath, M. F.
    Zopf, Y.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 67 (06): : 859 - 866
  • [43] Fecal Microbiota Transplantation for Clostridium difficile Infection A Systematic Review
    Drekonja, Dimitri
    Reich, Jon
    Gezahegn, Selome
    Greer, Nancy
    Shaukat, Aasma
    MacDonald, Roderick
    Rutks, Indy
    Wilt, Timothy J.
    ANNALS OF INTERNAL MEDICINE, 2015, 162 (09) : 630 - U230
  • [44] Experience with fecal microbiota transplantation in the treatment of Clostridium difficile infection
    Vigvari Szabolcs
    Nemes Zsuzsanna
    Vincze Aron
    Solt Jeno
    Sipos David
    Feiszt Zsofia
    Kappeter Agnes
    Kovacs Beata
    Peterfi Zoltan
    ORVOSI HETILAP, 2014, 155 (44) : 1758 - 1762
  • [45] Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection
    Zellmer C.
    De Wolfe T.J.
    Van Hoof S.
    Blakney R.
    Safdar N.
    Infectious Diseases and Therapy, 2016, 5 (2) : 155 - 164
  • [46] Fecal microbiota transplantation for Clostridium difficile infection: back to the future
    Borgia, Guglielmo
    Maraolo, Alberto Enrico
    Foggia, Maria
    Buonomo, Antonio Riccardo
    Gentile, Ivan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (07) : 1001 - 1014
  • [47] SUCCESSFUL THERAPY OF CLOSTRIDIUM DIFFICILE INFECTION WITH FECAL MICROBIOTA TRANSPLANTATION
    Konturek, Peter C.
    Dieterich, Walburga
    Neurath, Markus
    Zopf, Yurdaguel
    GASTROENTEROLOGY, 2017, 152 (05) : S341 - S341
  • [48] Fecal Microbiota-Transplantation for recurring Clostridium difficile Infection
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (09): : 830 - +
  • [49] Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers
    Lo Vecchio, Andrea
    Cohen, Mitchell B.
    CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (01) : 47 - 53
  • [50] FECAL MICROBIOTA TRANSPLANTATION IN CHILDREN WITH RECURENT CLOSTRIDIUM DIFFICILE INFECTION
    Pierog, Anne
    Mencin, Ali
    Reilly, Norelle Rizkalla
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (11) : 1198 - 1200
12345